Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ERYTHROMYCIN ESTOLATE

ERYTHROMYCIN ESTOLATE

Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ERYTHROMYCIN ESTOLATE is listed in Drugs@FDA under application 062237 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor IVAX SUB TEVA PHARMS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN ESTOLATE is listed in Drugs@FDA under application 062237 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor IVAX SUB TEVA PHARMS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.